7654465111

List of Trials

Send Us A Message

Have questions for us? Contact us to find out more.

  • This field is for validation purposes and should be left unchanged.

Lymphoma

April 25, 2019

  • I-MAB Biopharma, Co., LTD-TJ011133ED1101 which is a Phase 1 Study of TJ011133 Administered alone or in combination with Pembrolizumab or Rituximab in subjects with Relapsed/Refractory Advanced Solid Tumors and Lymphoma